Thomas Appleby, MD
Vascular Surgery · North Charleston, SCNPI 1801985007
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 96.9% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2023 at $20,451 and has fallen 70.1% since, to $6,119 in 2025. Among vascular surgery clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $539.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$86K
- Medtronic$554
- W. L. Gore & Associates, Inc.$466
- Lemaitre Vascular, Inc.$257
- Stryker$216
- Silk Road Medical, Inc.$201
- plus $1K from 14 others
What the payments were for
- Consulting fees$34,50039%
- Speaking & faculty fees$46,43152%
- Travel & lodging$4,8145%
- Food & beverage$3,2574%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 75 | $86,286 |
| Medtronic(2 entities) | 21 | $554 |
| W. L. Gore & Associates, Inc. | 8 | $466 |
| Lemaitre Vascular, Inc. | 7 | $257 |
| Stryker | 4 | $216 |
| Silk Road Medical, Inc. | 2 | $201 |
| Biocompatibles, Inc. | 4 | $192 |
| Boston Scientific | 8 | $161 |
| E.r. Squibb & Sons, L.L.C. | 10 | $153 |
| Bard Peripheral Vascular, Inc. | 2 | $93 |
| Smith+Nephew | 4 | $73 |
| Pfizer | 4 | $67 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $56 |
| Johnson & Johnson | 4 | $55 |
| Angiodynamics, Inc. | 3 | $41 |
| KCI USA, Inc. | 2 | $34 |
| Convatec Inc. | 2 | $32 |
| Cook Medical LLC | 2 | $30 |
| Medela LLC | 1 | $22 |
| Cardiva Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INDEPENDENCE MIS$15,500
- MARS Anterior Retractor$15,208
- ALIF$12,031
- CORBEL$7,898
- MONUMENT$7,746
- MARS Lateral ALIF$6,621
- RISE-L$6,366
- Excelsius - GPS$4,018
- ExcelsiusGPS Robotic Navigation System$3,500
- INDEPENDENCE$3,000
- EXCELSIUS$2,500
- MARS 3V/3VL$692
- MARS ANT RETRACTOR$301
- ENROUTE Transcarotid Stent$177
- ENROUTE Transcarotid Neuroprotection System$177
- In-Line ALIF$150
- GORE EXCLUDER AAA Endoprosthesis$148
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$123
- VARITHENA$119
- TurboHawk$111
How this compares
$89,002 in reported general payments places this provider in the 90th percentile of 99 vascular surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $24,912 |
| XareltoRivaroxaban | 12 | $13,078 |
| ClopidogrelClopidogrel Bisulfate | 54 | $879 |
| Cilostazol | 19 | $401 |
| Tramadol Hcl | 28 | $60 |
| Mupirocin | 11 | $60 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $46 |
| Diazepam | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $67 | $24,91224 claims |
| Johnson & JohnsonXarelto | $55 | $13,07812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 99 vascular surgery providers in South Carolina.
Other vascular surgery in North Charleston
- Kenneth DesartNorth Charleston$6K
- John RossOrangeburg$847K
- David DeatonColumbia$609K
- Mathew WoosterWest Columbia$443K
- Sagar GandhiGreenville$236K
- Ravi VeeraswamyCharleston$164K
- Gerald FortunaWest Columbia$143K
- Kristian HochbergCharleston$106K
- Joseph BlasGreenville$101K
- Zachary ArthursCharleston$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.